← WEST PHARMACEUTICAL SERVICES INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $203.0m | $235.9m | $337.4m | $439.1m | $615.5m | $762.6m | $894.3m | $853.9m | $484.6m | $791.3m | |
| Inventory, Net | $199.3m | $215.2m | $214.5m | $235.7m | $321.3m | $378.4m | $414.8m | $434.7m | $377.0m | $443.9m | |
| Assets, Current | $641.9m | $743.5m | $894.4m | $1.1b | $1.4b | $1.7b | $1.9b | $1.9b | $1.5b | $2.0b | |
| Property, Plant and Equipment, Net | $778.3m | $855.0m | $822.0m | $839.3m | $943.2m | $1.1b | $1.2b | $1.4b | $1.6b | $1.7b | |
| Goodwill | $103.0m | $107.7m | $105.8m | $107.8m | $111.1m | $109.9m | $107.3m | $108.5m | $106.0m | $109.9m | |
| Intangible Assets, Net (Excluding Goodwill) | $23.3m | $21.7m | $20.3m | $29.8m | $30.5m | $23.0m | $18.4m | $15.1m | $10.8m | $7.7m | |
| Operating Lease, Right-of-Use Asset | — | — | $0 | $70.1m | $68.3m | $69.3m | $104.4m | $99.2m | $104.5m | $117.0m | |
| Other Assets, Noncurrent | $21.3m | $23.4m | $20.5m | $24.7m | $23.4m | $39.2m | $38.1m | $21.3m | $74.3m | $80.1m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $200.5m | $253.2m | $288.2m | $319.3m | $385.3m | $489.0m | $507.4m | $512.0m | $552.5m | $574.4m | |
| Assets | $1.7b | $1.9b | $2.0b | $2.3b | $2.8b | $3.3b | $3.6b | $3.8b | $3.6b | $4.3b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $9.6m | $10.1m | $9.3m | $16.0m | $17.7m | $17.9m | $22.7m | |
| Accounts Payable, Current | $122.0m | $138.1m | $130.4m | $156.8m | $213.1m | $232.2m | $215.4m | $242.4m | $239.3m | $253.7m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $62.4m | $60.4m | $63.0m | $93.0m | $84.5m | $81.8m | $95.6m | |
| Deferred Revenue, Current | $1.5m | $1.5m | — | $27.5m | $51.0m | $48.7m | $57.3m | $41.7m | $49.6m | $51.9m | |
| Deferred Revenue, Noncurrent | $12.9m | $11.4m | — | — | — | — | — | — | — | — | |
| Dividends Payable, Current | $9.5m | $10.4m | $11.3m | $11.8m | $12.6m | $13.4m | $14.1m | $14.8m | $15.2m | $15.8m | |
| Long-term Debt, Current Maturities | — | — | — | — | $2.3m | $44.2m | $2.2m | $134.0m | $0 | $0 | |
| Long-term Debt, Excluding Current Maturities | $226.2m | $197.0m | $196.0m | $255.0m | $252.9m | $208.8m | $206.7m | $72.8m | $202.6m | $202.8m | |
| Liabilities, Current | $241.0m | $279.5m | $283.7m | $341.6m | $503.4m | $594.1m | $519.0m | $671.8m | $550.4m | $654.9m | |
| Deferred Income Tax Liabilities, Net | — | — | — | — | $10.4m | $4.9m | $14.3m | $12.7m | $20.5m | $23.0m | |
| Other Liabilities, Noncurrent | $47.2m | $42.6m | $33.6m | $41.2m | $31.8m | $38.2m | $51.6m | $58.5m | $62.2m | $75.2m | |
| Liabilities | $599.2m | $582.9m | $582.6m | $768.2m | $939.3m | $978.4m | $931.9m | $948.5m | $961.1m | $1.1b | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $18.4m | $18.8m | $18.8m | $18.8m | $18.8m | $18.8m | $18.8m | $18.8m | $18.8m | $18.8m | |
| Additional Paid in Capital | $260.4m | $309.3m | $282.0m | $272.7m | $267.3m | $249.0m | $232.2m | $120.2m | $22.1m | $0 | |
| Retained Earnings (Accumulated Deficit) | $1.1b | $1.2b | $1.4b | $1.5b | $1.8b | $2.5b | $3.0b | $3.5b | $4.0b | $4.4b | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($186.8m) | ($117.3m) | ($154.2m) | ($149.6m) | ($110.6m) | ($159.6m) | ($183.0m) | ($143.8m) | ($258.1m) | ($105.5m) | |
| Stockholders' Equity Attributable to Parent | — | — | — | — | $1.9b | $2.3b | $2.7b | $2.9b | $2.7b | $3.2b | |
| Liabilities and Equity | $1.7b | $1.9b | $2.0b | $2.3b | $2.8b | $3.3b | $3.6b | $3.8b | $3.6b | $4.3b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.